A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
